Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase - Wikidata - wikimedia - TriplyDB

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

http://www.wikidata.org/entity/Q28115041

about

Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function ACE2 gene expression is up-regulated in the human failing heart Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and Differences Review article: pancreatic renin-angiotensin systems in health and disease The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors Quantitative mRNA expression profiling of ACE 2, a novel homologue of angiotensin converting enzyme Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function Physiology of kidney renin Pharmacological effects of AVE 0991, a nonpeptide angiotensin-(1-7) receptor agonist Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension New perspectives in the renin-angiotensin-aldosterone system (RAAS) IV: circulating ACE2 as a biomarker of systolic dysfunction in human hypertension and heart failure Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction Interactions between apelin and angiotensin II on rat portal vein The role of angiotensin-(1-7) receptor Mas in spermatogenesis in mice and rats The counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cells Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation Novel peptide inhibitors of angiotensin-converting enzyme 2.Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.ACE2 activation promotes antithrombotic activity.Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats.Effects of exercise training on circulating and skeletal muscle renin-angiotensin system in chronic heart failure rats Therapeutic implications of the vasoprotective axis of the renin-angiotensin system in cardiovascular diseases.Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.Association between serum angiotensin-converting enzyme 2 levels and postoperative myocardial infarction following coronary artery bypass grafting.Modulation of canine cardiac sodium current by Apelin Role of the Vasopressin/Apelin Balance and Potential Use of Metabolically Stable Apelin Analogs in Water Metabolism Disorders.Addressing the theoretical and clinical advantages of combination therapy with inhibitors of the renin-angiotensin-aldosterone system: antihypertensive effects and benefits beyond BP control.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system Chronic AT2 receptor activation increases renal ACE2 activity, attenuates AT1 receptor function and blood pressure in obese Zucker rats.Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice.

P2860

7c24a2e279a693ed28e2d4f30c7575196f8c529e

P248

Q24300310-7403592A-C9A5-43FA-A6CB-250F456B5302 Q24311938-13B7CD16-A33D-4420-A617-90A0D240897D Q24633556-5BA861E4-6730-4E74-B040-62A854B978E0 Q24794580-624D37A0-2A21-449F-9295-59DA0422C38A Q26767412-A127A520-10B1-4C69-BA67-1EEFB02F1ECD Q26821967-90AE330B-3308-4D22-B9BB-DF630036A118 Q26823573-A6E97323-9133-48E8-883B-E265D6E71670 Q26823618-53E82432-5E3F-468B-B98D-DD9359503CE0 Q27643059-4DD10258-983F-43E6-A548-FA82FF9C2266 Q28077454-3594BE6C-0D4C-4C11-9040-FA95E3BAE6D3 Q28188160-4F26FAB0-E752-40B8-AE23-C54F59D2E639 Q28216431-A6BECEF2-3C32-4409-ABA7-350BE952E537 Q28264715-4FD48BDC-3D32-425E-9D26-D947DE2D4106 Q28279771-FBB6278F-8CBA-405D-8D5E-BEB38AF8505C Q28282619-9FB5591C-300A-48B5-844F-F2F2898B1223 Q28301752-B68BFB53-076B-47E1-8F48-98F81ADD4DCE Q28541744-B43DF557-45EE-4240-93A1-E1DA71C890C0 Q28569684-8B48A26B-107F-44C5-A1D6-B3C332EA7D40 Q28573763-C469E5EA-CB90-4DBC-93D7-AB416165647B Q28575188-717E9090-5C08-4EF6-B298-A70C98D15DC5 Q28575682-6D63E087-EB37-47A6-921D-2DB3227293FD Q28583180-B172DDBF-AC82-4FB5-9491-62F424F96013 Q28585962-A111EE9E-2061-4A47-BB78-47DE49040351 Q31133376-D6CC8FD6-8880-4FA7-96AA-EB39B750269F Q33319072-42D813DD-7CF8-4084-9C56-1D17C99DD981 Q33611250-7B9167FA-B554-43FD-B6E1-1142143D9467 Q33639490-CD3AB3D0-A6A1-4266-9A88-5BCF7FFFC60C Q33648557-986BC1D3-A285-4427-8BE8-AEC9ADF642FD Q33654750-D32DB2B5-F32D-4592-B53C-11BDAD885F0A Q33677369-3D962ACE-A9AF-4476-8282-F4F1B6D44932 Q33684855-36C193E8-A8B0-4A57-B09B-5FC9575EF7AD Q33703037-471AFFBD-E291-47D5-8705-90C6F3DD9BCF Q33706369-2A93D958-9B7D-4934-A392-AB4D09682D5F Q33724481-5D5B0EED-8161-45EA-B09B-99E91C055921 Q33742305-41D2C54C-77F4-4FD2-BA2D-09CA37855A02 Q33783689-EA72516F-801A-4229-8224-6518FBF5DBDD Q33795353-5EDFBFE8-2190-47AA-8493-7AC4FB24C7CC Q33799399-750B08E2-E412-4868-A05C-F90B283CDD84 Q33881270-ADE572CF-971F-461A-BFEB-52A301852470 Q33895288-53A7D74B-1C37-474E-B599-50E7F810C9A2

P2860

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

http://www.wikidata.org/entity/Q28115041

description

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

artículu científicu espublizáu en 2002

@ast

im April 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2002/04/26)

@sk

vědecký článek publikovaný v roce 2002

@cs

wetenschappelijk artikel (gepubliceerd op 2002/04/26)

@nl

наукова стаття, опублікована у квітні 2002

@uk

name

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@ast

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@en

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@nl

type

label

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@ast

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@en

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@nl

prefLabel

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@ast

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@en

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@nl

P1433

Q28115041-423217FD-A800-4223-B8EF-F52E55CA3542

P1476

Q28115041-402C9061-54A8-47C5-B687-201F72C5A0AF

P2093

Q28115041-0142D9EA-BC99-4889-8850-E1A785699E60

Q28115041-2A7719E3-AFA2-407B-8193-6E659D9CD672

Q28115041-3240F834-6D24-4AC8-8F04-376E0B01C987

Q28115041-436BEAD5-C681-4832-B680-E74B30D80C6C

Q28115041-5F515522-C695-427D-A7F7-5C250931F0CD

Q28115041-60AADE45-4122-4F0E-9961-543D1DDC4A0D

Q28115041-72332B1C-7A76-4513-9BCE-B8782B7ED2E7

Q28115041-9EA215FD-BBF3-460C-A010-8ACCAA91851F

Q28115041-A15109A7-7049-49AE-ADDB-78F88B2F0C80

Q28115041-A9396759-828F-4D8F-B5DA-93B493A61F87

P2860

Q28115041-0052D5C6-0989-4E35-B86D-AFD0D38B49FE

Q28115041-2014B483-3CEA-420C-A112-2361E1C6EDA2

Q28115041-26BE01F0-8207-4E59-B956-F9B7A79DA5B5

Q28115041-35D57430-9AFF-4385-B71B-CDC4AD71C59D

Q28115041-53275246-A5CF-4DDA-B831-2E7B136E533D

Q28115041-5C819408-7E06-473D-9A9F-60B9677E59CC

Q28115041-7CA79E70-BF91-4FFD-91B5-F0ED05C7A03D

Q28115041-7CEE56B7-180A-4663-9F51-385C5891DA18

Q28115041-8C5DC882-9203-43B6-8068-A8F8230E7734

Q28115041-8D6BBBE8-49C6-4F46-BBDE-E151BDEC08BF

P304

Q28115041-F412D77B-2528-4613-AFB7-D176181DAE37

P31

Q28115041-FF959378-F9CF-490D-88D3-A1D0ED3E65A2

P3181

Q28115041-8113ACC0-B011-44A9-9987-5CC9CD1F0E57

P356

Q28115041-60EC24C8-B3C7-4C80-A97D-C7CCCF20EA3C

P407

Q28115041-6A698781-DF98-401C-A0BC-7A6D13820692

P433

Q28115041-5FA67F01-1815-42C7-B91E-2D95168C73D5

P478

Q28115041-5EC95DE9-DE78-4CC7-A29E-2AD321FF4DB8

P577

Q28115041-2BD7488D-4CDB-4E36-A9B7-08202BCF47BF

P698

Q28115041-7359287B-E31E-44FC-B228-97D69EE3EAF0

P921

Q28115041-7F04E24C-703C-47EB-BB03-49941FAB1AB9

Q28115041-E7CB5AA9-931A-4D9C-8DD3-F56B9E5AB1E3

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Hydrolysis of biological pepti ...... nzyme-related carboxypeptidase

@en

P2093

Andrew Nichols

http://www.w3.org/2001/XMLSchema#string

Chad Vickers

http://www.w3.org/2001/XMLSchema#string

Elizabeth Baronas

http://www.w3.org/2001/XMLSchema#string

Frank Hsieh

http://www.w3.org/2001/XMLSchema#string

James Gavin

http://www.w3.org/2001/XMLSchema#string

Jin Tang

http://www.w3.org/2001/XMLSchema#string

Kevin Godbout

http://www.w3.org/2001/XMLSchema#string

Larry Dick

http://www.w3.org/2001/XMLSchema#string

Michael Patane

http://www.w3.org/2001/XMLSchema#string

Paul Hales

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

Catalysis of angiotensin I hydrolysis by human angiotensin-converting enzyme: effect of chloride and pH

Neurotensin and neurotensin receptors

Characterization of apelin, the ligand for the APJ receptor

[(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin

Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.

Dynorphin: friend or foe?

The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins.

P304

14838–14843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3429942

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.M200581200

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11815627

http://www.w3.org/2001/XMLSchema#string

P921

metallocarboxypeptidase activity

Angiotensin I converting enzyme 2